Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 10.24
(0.29%)
CNY 10.24
(0.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 640.85 Million CNY | -10.0% |
| 2022 | 701.56 Million CNY | 11.08% |
| 2021 | 631.58 Million CNY | 28.12% |
| 2020 | 492.96 Million CNY | -5.27% |
| 2019 | 520.37 Million CNY | 9.21% |
| 2018 | 476.51 Million CNY | -0.31% |
| 2017 | 478.01 Million CNY | 8.03% |
| 2016 | 442.48 Million CNY | 17.47% |
| 2015 | 376.67 Million CNY | 16.26% |
| 2014 | 323.99 Million CNY | 10.63% |
| 2013 | 292.85 Million CNY | 35.08% |
| 2012 | 216.79 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 114.75 Million CNY | -24.35% |
| 2024 Q2 | 162.39 Million CNY | 41.51% |
| 2024 Q3 | 136.75 Million CNY | -22.33% |
| 2023 FY | 631.43 Million CNY | -10.0% |
| 2023 Q2 | 206.99 Million CNY | 55.55% |
| 2023 Q3 | 139.66 Million CNY | -32.53% |
| 2023 Q4 | 151.69 Million CNY | 8.61% |
| 2023 Q1 | 133.07 Million CNY | -13.72% |
| 2022 Q3 | 209.14 Million CNY | 16.87% |
| 2022 Q2 | 178.95 Million CNY | 12.39% |
| 2022 Q1 | 159.22 Million CNY | 1.54% |
| 2022 FY | 701.56 Million CNY | 11.08% |
| 2022 Q4 | 154.23 Million CNY | -26.25% |
| 2021 Q4 | 156.81 Million CNY | -13.3% |
| 2021 Q1 | 135.98 Million CNY | -7.47% |
| 2021 FY | 631.58 Million CNY | 28.12% |
| 2021 Q2 | 157.9 Million CNY | 16.12% |
| 2021 Q3 | 180.87 Million CNY | 14.54% |
| 2020 Q2 | 127.57 Million CNY | 72.07% |
| 2020 Q3 | 144.27 Million CNY | 13.09% |
| 2020 FY | 492.96 Million CNY | -5.27% |
| 2020 Q1 | 74.14 Million CNY | -49.58% |
| 2020 Q4 | 146.96 Million CNY | 1.87% |
| 2019 Q3 | 128.17 Million CNY | -4.87% |
| 2019 Q2 | 134.73 Million CNY | 22.02% |
| 2019 Q1 | 110.41 Million CNY | -19.72% |
| 2019 FY | 520.37 Million CNY | 9.21% |
| 2019 Q4 | 147.05 Million CNY | 14.73% |
| 2018 Q4 | 137.54 Million CNY | 13.07% |
| 2018 Q1 | 103 Million CNY | -15.23% |
| 2018 FY | 476.51 Million CNY | -0.31% |
| 2018 Q2 | 114.31 Million CNY | 10.98% |
| 2018 Q3 | 121.64 Million CNY | 6.42% |
| 2017 Q1 | 101.3 Million CNY | -14.96% |
| 2017 FY | 478.01 Million CNY | 8.03% |
| 2017 Q4 | 121.51 Million CNY | 0.25% |
| 2017 Q3 | 121.2 Million CNY | -9.54% |
| 2017 Q2 | 133.99 Million CNY | 32.27% |
| 2016 FY | 442.48 Million CNY | 17.47% |
| 2016 Q2 | 107.27 Million CNY | 10.27% |
| 2016 Q3 | 118.8 Million CNY | 10.75% |
| 2016 Q1 | 97.28 Million CNY | -5.4% |
| 2016 Q4 | 119.12 Million CNY | 0.27% |
| 2015 Q4 | 102.83 Million CNY | 0.0% |
| 2015 Q2 | 86.48 Million CNY | 0.0% |
| 2015 Q1 | 86.48 Million CNY | -3.56% |
| 2015 FY | 376.67 Million CNY | 16.26% |
| 2015 Q3 | 102.83 Million CNY | 18.91% |
| 2014 Q1 | 73.23 Million CNY | 0.0% |
| 2014 Q2 | 73.23 Million CNY | 0.0% |
| 2014 FY | 323.99 Million CNY | 10.63% |
| 2014 Q3 | 89.67 Million CNY | 22.45% |
| 2014 Q4 | 89.67 Million CNY | 0.0% |
| 2013 FY | 292.85 Million CNY | 35.08% |
| 2012 FY | 216.79 Million CNY | 0.0% |